Big Pharma has a long history of price-gouging American patients by gaming the U.S. patent system and blocking competition from more affordable alternatives, like generics and biosimilars. Why? Because these anti-competitive tactics allow Big Pharma to maintain monopolies over their biggest money-makers. PhRMA recently launched a new ad campaign seeking to deflect scrutiny from Big […]